Tower Research Capital LLC (TRC) - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 58 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$158,000
+16.2%
7,813
+113.9%
0.00%0.0%
Q2 2021$136,000
+56.3%
3,652
+7.0%
0.00%
+300.0%
Q1 2021$87,000
-53.0%
3,414
-59.4%
0.00%
-83.3%
Q4 2020$185,000
+213.6%
8,405
+154.3%
0.01%
+500.0%
Q3 2020$59,000
-84.8%
3,305
-78.3%
0.00%
-93.8%
Q2 2020$387,000
+118.6%
15,227
+89.9%
0.02%
+6.7%
Q4 2019$177,000
+2850.0%
8,018
+1904.5%
0.02%
Q3 2019$6,000
-83.8%
400
-84.4%
0.00%
-100.0%
Q1 2019$37,000
+362.5%
2,569
+382.9%
0.00%
+100.0%
Q3 2018$8,000
-20.0%
532
-33.2%
0.00%0.0%
Q2 2018$10,000
-33.3%
797
-48.1%
0.00%0.0%
Q1 2018$15,000
-84.2%
1,536
-85.5%
0.00%
-91.7%
Q4 2017$95,000
+493.8%
10,560
+130.8%
0.01%
+500.0%
Q1 2017$16,000
-11.1%
4,575
-25.5%
0.00%0.0%
Q4 2016$18,000
+350.0%
6,137
+403.0%
0.00%
Q2 2016$4,000
-42.9%
1,220
-1.0%
0.00%
-100.0%
Q1 2016$7,000
-85.7%
1,232
-70.4%
0.00%
-87.5%
Q4 2015$49,000
+308.3%
4,167
+369.8%
0.01%
+700.0%
Q2 2015$12,000
-58.6%
887
-26.6%
0.00%
-75.0%
Q1 2015$29,000
+107.1%
1,208
+46.4%
0.00%
+300.0%
Q4 2014$14,000825
+8150.0%
0.00%
Q2 2014$0100.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders